How could hypoglycemia-inducing glycogen storage disease lead to hyperglycemia-induced mucormycosis?

Larry Nichols; Diana Alejandra Rios

doi:10.4322/acr.2020.149

Article / Autopsy Case Report

How could hypoglycemia-inducing glycogen storage disease lead to hyperglycemia-induced mucormycosis?

Larry Nichols; Diana Alejandra Rios

http://dx.doi.org/10.4322/acr.2020.149 Autops Case Rep, vol.10, n1, e2020149, 2020

PDF

PMC

Downloads: 0

Abstract

Mucormycosis is an increasingly frequent, difficult to diagnose, difficult to treat, often fatal infection, especially in patients with hyperglycemia from uncontrolled diabetes. Type I (von Gierke) glycogen storage disease is due to inherited deficiency of enzymes in glycogen metabolism, which causes hypoglycemia. This report is the case of a patient with von Gierke disease and a missed diagnosis of pulmonary mucormycosis. This report illustrates the importance of having a high index of suspicion for mucormycosis in the appropriate clinical context.

Keywords

Mucor, Lung Diseases, Fungal, Glycogen Storage Disease Type I, Autopsy

References

Serris A, Danion F, Lanternier F. Disease entities in mucormycosis.

J Fungi. 2019;5(1):E23. [https://doi.org/10.3390/jof5010023]. [PMID:30875744]

Hassan MIA, Voigt K. Pathogenicity patterns of mucormycosis: epidemiology, interaction with immune cells and virulence factors.

Med Mycol. 2019;57(Suppl 2):S245-56. [https://doi.org/10.1093/mmy/myz011]. [PMID:30816980]

Ibrahim AS, Voelz K. The mucormycete-host interface.

Curr Opin Microbiol. 2017;40:40-5. [https://doi.org/10.1016/j.mib.2017.10.010]. [PMID:29107938]

Prakash H, Chakrabarti A. Global epidemiology of mucormycosis.

J Fungi. 2019;5(1):E26. [https://doi.org/10.3390/jof5010026]. [PMID:30901907]

Jung J, Kim MY, Lee HJ, et al. Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis.

Clin Microbiol Infect. 2015;21(7):684.e11-8. [https://doi.org/10.1016/j.cmi.2015.03.019]. [PMID:25882362]

Sullivan T, Rana M. The reversed halo sign and mucormycosis.

Lancet Infect Dis. 2019;19(12):1379. [https://doi.org/10.1016/S1473-3099(19)30548-1]. [PMID:31782402]

Skiada A, Lass-Floerl C, Klimko N, Ibrahim A, Roilides E, Petrikkos G. Challenges in the diagnosis and treatment of mucormycosis.

Med Mycol. 2018;56(Suppl 1):93-101. [https://doi.org/10.1093/mmy/myx101]. [PMID:29538730]

Chavez JA, Brat DJ, Hunter SB, Velazquez Vega J, Guarner J. Practical diagnostic approach to the presence of hyphae in neuropathology specimens with three illustrative cases.

Am J Clin Pathol. 2018;149(2):98-104. [https://doi.org/10.1093/ajcp/aqx144]. [PMID:29365030]

Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.

Lancet Infect Dis. 2019;19(12):e405-21. [https://doi.org/10.1016/S1473-3099(19)30312-3]. [PMID:31699664]

Parikh NS, Ahlawat R.

Glycogen storage disease type I: von Gierke disease [Internet]. Treasure Island: StatPearls Publishing; 2019 [cited 2019 Dec 17]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534196/

Publication date:
02/06/2020

How could hypoglycemia-inducing glycogen storage disease lead to hyperglycemia-induced mucormycosis?

Larry Nichols; Diana Alejandra Rios

Abstract

Keywords

References

Links

Share

Autops Case Rep